Triptolide in Combination with the Gli1 Inhibitor GANT61 Eradicates Anaplastic Thyroid Cancer by Suppressing Cancer Stem Cell Self-Renewal and Enhancing Apoptosis and Pyroptosis
Yuqing Zhao, Yue Zhu, Shuying Zhong, Penggang Liu, Wei Li, Xiaoyun Mao, Xiulong Xu · 2026
Read Triptolide in Combination with the Gli1 Inhibitor GANT61 Eradicates Anaplastic Thyroid Cancer by Suppressing Cancer Stem Cell Self-Renewal and Enhancing Apoptosis and Pyroptosis by Yuqing Zhao, Yue Zhu, Shuying Zhong, Penggang Liu, Wei Li, Xiaoyun Mao, Xiulong Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13618228.txt.
Description
Yuqing Zhao and co-authors combine two drugs to corner anaplastic thyroid cancer. Their 2026 study targets the cancer stem cells that drive its resistance and recurrence. A Gli1 inhibitor attacks stem cell renewal but triggers a survival pathway that blunts it; triptolide, a natural compound, blocks exactly that pathway.
In two cell lines the pair killed synergistically, and in mouse tumors the combination not only shrank growth but prevented recurrence after treatment. The duo suppressed stem cell self-renewal and triggered two forms of cell death, including fiery pyroptosis driven by reactive oxygen. Blocking the survival pathway by gene knockout reproduced the synergy, confirming the mechanism. The authors propose the combination as a strategy for eradicating a cancer that currently outruns single drugs. Cell and mouse evidence is a beginning, not a treatment, and they present it as such.
Catalog record
| CREATOR | Yuqing Zhao, Yue Zhu, Shuying Zhong, Penggang Liu, Wei Li, Xiaoyun Mao, Xiulong Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |